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Can Clinical Genetics Laboratories be Sued for
Medical Malpractice?
Alexandra L. Foulkes, JessicaL. Roberts, PaulS. Appelbaum, Wendy
K. Chung, Ellen Wright Clayton, BarbaraEvans, Gary E. Marchant*
I. INTRODUCTION
From a legal perspective, is a clinical laboratory a healthcare provider?
Physicians are clearly healthcare providers who owe their patients the
associated fiduciary duties. It is less clear, however, which-if any-legal
duties genetic testing labs owe to the individuals who seek their services.
The question of whether clinical genetics laboratories are healthcare
providers for legal purposes may be thornier than it could initially appear.
Clinical genetics laboratories perform multiple tasks. Most significantly, they
sequence genetic samples and then interpret the results. As "next generation
sequencing" has become more accessible,' labs can generate and interpret
more sequence data for a growing number of clinical indications. 2 While

* Funding for this research was provided by NIH Grant 1R01HG010365-02, Development of
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Houston; Paul S. Appelbaum, Elizabeth K. Dollard Professor of Psychiatry, Medicine &
Law, Columbia University; Wendy K. Chung, Kennedy Family Professor of Pediatrics,
Director of Clinical Genetics Program, Columbia University; Ellen Wright
Clayton, Professor of Pediatrics, Professor of Health Policy, Professor of Law, Vanderbilt
University and Medical Center; Barbara J. Evans, Mary Ann & Lawrence E. Faust Professor
of Law, Professor of Electrical and Computer Engineering, Director of Center on
Biotechnology & Law, University of Houston; Gary E. Marchant, Regents Professor of Law,
Faculty Director of the Center for Law, Science and Innovation, Arizona State University.
Thank you to Elaine Fiala for her administrative support.
1 See Sara H. Katsanis & Nicholas Katsanis, Molecular Genetic Testing andthe Future of
Clinical Genomics, 14 NATURE REV. GENETICS 415, 415 (2013) (stating that "[g]enomic
technologies are reaching the point of being able to detect genetic variation in patients at
high accuracy and reduced cost").
2 To be clear, "generating genetic data" means several things, some of which sound in
laboratory services and some of which sound in the practice of medicine. Next generation
sequencing (NGS) involves: identifying the nucleotide sequences in a person's genome;
processing that information to draw probabilistic inferences about ways the person's genome
differs from a human reference genome, with the aim of identifying the person's genetic
variants; and then attempting to interpret the clinical significance of those variants, i.e., how
the person's health may be affected by the variants that were found. Before NGS, it was a
great challenge to characterize the nucleotide sequences and identify the person's variants.
NGS has made that easier. But the problem of interpreting what the variants mean is just as
challenging now as it was in the days of single-gene testing technologies. Id.
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standardized methods for generating and processing sequence data are in
place, the way labs interpret genetic data remains in flux.3 And, increasingly,
how a given laboratory interprets genetic data has become more salient4
because physicians rely on those interpretations in their medical practices.
These changes in data interpretation have brought new medical and legal
challenges. 5
In the process of generating potentially clinically relevant findings, next
generation sequencing also produces large amounts of data that currently lack
clinical significance. In fact, sequencing reveals many never before seen
genetic variations.6 As such, labs lack sufficient knowledge to designate
these variations as either pathogenic-disease-causing-or benign.
Consequently, labs classify them as variants of uncertain significance
(VUSs).8 VUSs are extremely common due to the large number of rare
variants in the genome, insufficient information about the normal distribution
of variants across populations, and the absence of biological functional data. 9
In fact, every patient who is sequenced currently has several VUSs.' 0
The understanding of genetic information evolves as scientists report new
findings, additional population data become available, and labs develop more
advanced computational tools." With time and more data, uncertain variants
See Sue Richards et al., Standards and Guidelinesfor the Interpretationof Sequence
Variants:A Joint Consensus Recommendation of the American College of Medical Genetics
and Genomics and the Associationfor MolecularPathology, 17 GENETICS MED. 1,2(2015)
(stating that "[i]n 2015, The American College of Medicine Genetics and Genomics
(ACMG) and the Association for Molecular Pathology issued professional guidelines for the
interpretation of sequence data"); see also Cristi Radford & Michele Gabree, Variants of
Uncertain Significance FrequentlyAsked Questions, THE ONCOLOGY NURSE (Sept. 9,
2019), http://www.theoncologynurse.com/ton-issue-archive/2018/july-2018-vol-11-no3/17516-variants-of-uncertain-significance. These guidelines are used merely as a
framework, recommending that sequence variants be classified into one of five categories
along a gradient, ranging pathogenic to benign. Id. Along with this framework, labs use
their own internal protocols and data; for example, different labs might weigh a piece of
evidence differently in their determination of a variant's classification, ultimately resulting
in different classifications of the same variant. Id.
4 Richards et al., supra note 3, at 9.
5 Cf Pengfei Liu et al., Reanalysis of Clinical Exome Sequencing, 380 NEW ENG. J. MED.
2478, 2479 (2019) (illustrating that not all physicians follow up with patients after results of
their genetic reanalysis have been received).
6 Richards et al., supra note 3, at 20.
3

7

Id.

8 Id.

9 See id. (stating that discovering new variants occurs when a gene has never been associated
with any patient phenotype or when the gene has been associated with a different phenotype
from that under consideration).
10See id. (noting "all individuals are expected to have approximately one de novo variant in
their exome or 100 in their genome").
" See Yvonne Stevens et al., Physicians'Dutyto Recontact and Update Genetic Advice, 14
PERSONALIZED MED. 1, 2 (2017) (noting that "[s]ome DNA sequencing laboratories and
services have taken it upon themselves to update previous variant classifications").

https://lawecommons.luc.edu/annals/vol29/iss1/5

2

Foulkes et al.: Can Clinical Genetics Laboratories be Sued for Medical Malpractic

2020

Annals of Health Law and Life Sciences

should be reclassified as benign or pathogenic. In most cases, VUSs end up
being benign and having no adverse clinical implications. 12 Rarely, variants
previously classified as pathogenic may be found to be benign or vice versa."
Before a stable scientific consensus emerges, labs may reclassify the variant14
multiple times, moving it from pathogenic to non-pathogenic or the reverse.
As labs face the challenge of dealing with this data, which may-or may
not-gain clinical significance, the potential for legal liability raises the
stakes of accurate variant interpretation.
Consider this hypothetical. A patient visits her primary care physician
(PCP) to discuss her family history of colon cancer. As a result of their
discussions, her doctor orders a genetic test for hereditary cancers from a
clinical laboratory. Following the doctor's orders, the lab sequences the
patient's DNA and sends a report to her PCP. That report indicates that the
patient has no known pathogenic genetic variants, but the lab also notes a
number of VUSs. The PCP, relying on those findings, reports that there is
nothing specifically actionable for the PCP or the patient. Three years later,
the patient is diagnosed with ovarian cancer. She asks whether her previous
genetic test indicated that she was at increased risk. Her doctor asks the lab
to look back at her previous testing. The lab finds that, six months ago, a
peer-reviewed study linked one of the patient's VUS to a risk of Lynch
syndrome, which is associated with colon, uterine, and ovarian cancer. Had
the patient known of this risk, she could have taken steps to screen for these
cancers or had a hysterectomy and oophorectomy to reduce the risk of uterine
and ovarian cancer. Yet no one communicated this information to the patient,
and the patient dies of the disease.' 5 Clinical genetics laboratories need to
consider the scope of their long-term obligations to update test results in
response to evolving knowledge. This Article contemplates the potential tort
liability of those labs.
If the patient's family decides to sue the lab, which body of law will
govern the claim? Is it medical malpractice with all of its accompanying
doctrines? 16 Or is her family's claim more properly construed as ordinary
See Thomas Salvin et al., The Effects of Genomic Germline Variant Reclassificationon
Clinical Cancer Care, 10 ONCOTARGET 417, 420 (2019) (noting that of the variants that
12

underwent any reclassification, only 25/322 (7.8%) resulted in a change in actionability).
13 See id. (stating that of the 36% were actionable downgrades-likely pathogenic or
pathogenic reclassified to benign, likely benign, or VUS categories).
14 See id. at 419 (noting that in February 2017, 1743 participants had 1816 variants analyzed
and of these, 294 individuals (16.9%) had 315 variants (17.3%) reclassified).
15 For a similar hypothetical, see Stevens et al., supra note 11, at 1.
16
See, e.g., Williams v. Quest Diagnostics, Inc., 353 F. Supp. 3d 432, 442 (D.S.C. 2018)
(citing Dawkins v. Union Hosp. Dist., 408 S.C. 171, 758 S.E.2d 501, 504-05 (2014)
(explaining that differentiating between medical negligence and malpractice and ordinary
negligence depends on facts of each case)). It is likely that the family would also bring an
action against the PCP directly, though the focus of this Article is the action taken against
laboratories.
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negligence? The answer to these questions has serious consequences for
plaintiffs, laboratories, and the attorneys who represent them.
The lawyers litigating cases against clinical laboratories will have to
anticipate which body of substantive law the courts will apply. 17 All fifty
states have adopted some variation of a medical malpractice statute. The term
malpractice statute, as used here, is broadly defined to include: (1) statutes
that directly bear on the conduct of malpractice suits in a state, such as
statutes defining the tort standard of care, the statutes of repose/limitations,
and medical malpractice reform statutes; and (2) medical practice acts and
other general state laws relating to medical professional licensure and
licensing and regulation of healthcare facilities, to the extent that these
statutes help determine who falls within the scope of a state's malpractice
doctrines. Typically, malpractice statutes apply only to healthcare
providers.' Who constitutes a healthcare provider, however, isn't always
immediately clear from the face of the statute.19
Medical malpractice laws have far-reaching implications. For example,
malpractice legislation often caps damages.20 In fact, thirty out of the fifty
states have established damage caps, 21 ranging from $250,00022 to
$2,250,000.23

Some limit compensatory damages, while others restrict

noneconomic damages. 24 These caps might lessen plaintiffs' recoveries,
17 Patients, doctors, and laboratories may all be in different states. Some labs have physical
facilities in multiple states but have headquarters or corporate offices in one state. Many
civil procedure issues are implicated by genetic malpractice claims against clinical
laboratories. These are beyond the scope of this Article and will be fully considered in a
subsequent paper. Jessica L. Roberts et al., Issues in the Legal Liability of Clinical Genetics
Laboratories(unpublished manuscript) (on file with author).
18 See, e.g., ARK. CODE ANN. § 16-114-201 (West 2013) (illustrating that the statute for
malpractice includes the term "medical care provider"); CAL. CIV. PROC. CODE ANN. §
3333.2(1), 425.13 (West 2016) ("[h]ealth care provider"); CONN. GEN. STAT. ANN. § 52-184c
(West 2019) ("health care provider"); LA. STAT. ANN. § 40:1231.1 (2015) ("healthcare
provider").
19See also infra notes 85, 88 and accompanying text (illustrating that the definition of
healthcare provider varies from state to state, and that the definitions have room for
ambiguity).
20
MalpracticeCaps in All 50 States, MWLER & Zois LLC (Feb. 2019),
https://www.millerandzois.com/malpractice-damage-caps.html [hereinafter Malpractice
Caps]; Cf Moore v. Mobile Infirmary Ass'n, 592 So.2d 156, 172 (Ala. 1991) (finding that
limiting noneconomic damages recoveries against physicians violated the state constitution
and the U.S. Constitution).
21 MalpracticeCaps, supra note 20 (noting that caps have been declared unconstitutional in
eight states).
22 See MONT. CODE ANN. § 25-9-411 (West 2019) (where malpractice claims in Montana are
capped at $250,000).
23 See NEB. REV. STAT. ANN. § 44-2825 (West 2019) (where malpractice claims in Nebraska
are capped at $2,250,000).
24 See Catherine M. Sharkey, Unintended Consequences of Medical MalpracticeDamage
Caps, 80 N.Y.U. L. REv. 391, 396-97 (2005) (highlighting the variation of total
compensatory, punitive and noneconomic damages in medical malpractice caps).
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particularly for noneconomic damages.25

Additionally, malpractice statutes often include statutes of limitations
shorter than those that apply to ordinary negligence claims. For example,
Louisiana, Nevada, and North Carolina require malpractice actions to be26
brought no later than one year after the discovery of an actionable injury.
Moreover, statutes of repose, which further restrict the ability of plaintiffs to
recover, may also apply in medical malpractice-but not general
negligence-cases. 2 7 These provisions actually provide more robust
protection to healthcare providers than statutes of limitations because they do
not allow equitable tolling.28 In malpractice cases involving genetics, statutes
of repose have been important 29 because it may take a plaintiff several years
to discover a genetic condition.30 And while some courts have been
sympathetic that genetics cases may raise unique issues, others have not.3 '
Malpractice statutes may also compel arbitration, modify expert witness
standards, or shift the costs and burdens of litigation from the provider to the
injured patient.3 2 Requiring patients to arbitrate before they can sue could
limit how many medical malpractice claims go to court.33 Yet, even when
cases are not sent to arbitration, the vast majority are settled rather than

25 See

id. at 399 (providing pain and suffering as an example of non-economic damages).
§ 5628 (2019); NEV. REV. STAT. § 41A.097 (2019); N.C. GEN. STAT. § 115 (2019).
27 See Gary E. Marchant et al., Unjust Timing Limitations in Genetic Malpractice Cases, 83
ALB. L. REV. (forthcoming 2019).
28 See Gary E. Marchant & Rachel A. Lindor, Genomic Malpractice:An Emerging Tide or
Gentle Ripple?, 71 FOOD & DRUG L. J. 1, 28 (2018) (providing examples of cases which
were dismissed after plaintiff brought the action upon discovery but after the statute of
repose tolled).
29 See id. (summarizing the Michigan Court of Appeals' dismissal of a case where the
physician failed to take action on a child's prolonged QT finding and the plaintiff family
learned about the physician's failure after the child died four years later, but after the statute
of repose tolled).
30 See id. (providing two examples of cases dismissed because the statutes of repose tolled
where the plaintiffs discovered the genetic condition four and five years after the negligent
acts occurred); id. (providing two examples of cases dismissed because the statutes of repose
tolled where the plaintiffs discovered the genetic condition four and five years after the
negligent acts occurred); id. at 15 (noting that "[genetic] malpractice claims take
approximately twice as long as other medical malpractice cases to resolve is likely due to the
often-cryptic nature of genetic conditions which may not become clear for many years").
31 Compare Hauserv. Kaufman, 972 N.E.2d 927, 938 (Ind. Ct. App. 2012) (stating "[w]e
are, of course, fully cognizant that we are permitting a nearly four-decade old claim of
malpractice to proceed at this time"), with Kush v. Lloyd, 616 So.2d 415, 420-21 (Fla.
1992) (holding that a family's action was barred by the statute of repose, although the birth
that created the cause of action did not arise until after the statute of repose had expired).
32 See Shirley Qual, A Survey ofMedical Malpractice Tort Reform, 12 WILLIAM MITCHELL
L. REV. 418, 429, 432, 436 (1986).
33 Lauren K. Saunders, The Questfor Balance: Public Policy & Due Process in Medical
MalpracticeArbitrationAgreements, 23 HARv. J. ON LEGIS. 267, 268 (1986).
26 LA. STAT. ANN.
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litigated.34
Finally, while ordinary negligence only requires the providers of goods or
services to act reasonably, medical malpractice law generally requires
healthcare providers to meet medical standards of care and to perform the
associated legal duties.35
Taken together, all of these features of malpractice law share a common
denominator: they can have a tremendous impact on the outcomes of claims
construed as medical malpractice. Plaintiffs may try to escape these harsh
consequences by framing their claims as general negligence. This strategy is
sometimes successful and sometimes not.36
Williams v. Quest Diagnostics,Inc.
A current case playing out in the South Carolina courts, Williams v. Quest
Diagnostics, demonstrates the increasing relevance of these issues. 37 As this
case makes clear, the question of liability will-to some extent-turn on
whether clinical laboratories are healthcare providers for purposes of medical
malpractice statutes.38 In Williams, a mother sued Athena Diagnostics on
behalf of her deceased son for failing to correctly diagnose the pathogenicity
of a genetic variant.39 Christian Williams was born in the summer of 2005
and for four months seemed to be developing normally. 40 At the four-month
mark, he began to suffer from severe seizures. 4 ' When treatments failed and
his condition worsened, the family consented to genetic testing by Athena's
laboratory to identify mutations in a specific gene-SCNA.42 The SCN]A
gene encodes sodium channels, and defects in sodium channels in the brain's
neurons can cause seizures.4 3
On June 30, 2007, Athena reported that Christian had a SCN]A variant,
which the lab classified as a VUS. 44 Unbeknownst to Christian's parents, two
publications, one released in 2006 and another in 2007-both of which
See Theodore Eisenberg, Mhat Is the Settlement Rate and IThy Should We Care?, 6 J.
EMPIRICAL LEGAL STUD. 111, 111 (2009) (noting that "[o]f major case categories, tort cases
to have the highest settlement rates").
15 Yvette Brazier, MedicalMalpractice: Mhat Does It Involve ?, MED. NEWS TODAY (Apr.
5,
2017), https://www.medicalnewstoday.com/articles/248175 .php.
36 See generallyHo-Rathv. R.I. Hosp., 89 A.3d 806, 812 (R.I. 2014) (stating that "in the
absence of clear statutory language to the contrary, the legislature did not intend for
negligence actions against laboratories to fall under the ambit of medical malpractice").
37
Id. at 436-37.
38 Williams v. Quest Diagnostics, Inc., 353 F. Supp. 3d 432, 438 (D.S.C. 2018).
'9 Id. at 437, 442.
40
Id. at 436.
41 Id
14

42

Id.

Compl. for Pet'r at 12, Williams v. Quest Diagnostics, Inc., 353 F. Supp. 3d 432, 437
(D.S.C. 2018) (No. 2016-CP-40-01166) [hereinafter Complaint for Petitioner].
44 Williams, 353 F. Supp. 3d at 436.
41
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predated Christian's testing-identified Christian's variant in patients with
Dravet Syndrome, a severe form of epileptic encephalopathy.45 In fact,
Athena's chief compliance laboratory director, who signed off on Christian's
test results, was an author on one of those publications.46
Relying on the laboratory's report, however, Christian's doctors rejected
a diagnosis of Dravet Syndrome.47 He received additional doses of
medications that tragically exacerbate seizures in patients with Dravet
Syndrome.48 In 2008, following a seizure, Christian died.49
Williams' clinical geneticist requested a copy of the 2007 report in 2014.50
Athena then issued a revised 2015 report. 5 1 The updated report correctly
identified Christian's variant as pathogenic. 52 In light of this new
information, a pediatric neurologist concluded that had Christian's Dravet
Syndrome been properly diagnosed and treated, he could have avoided the
fatal seizure.53 His mother then sued Athena for wrongful death.54
The Williams case was promptly removed to federal court.55 Before
considering any of the claims, the district court certified a question to the
South Carolina Supreme Court.56 The judge asked whether, under South
Carolina state law, a clinical genetics laboratory is a licensed healthcare
provider.5 7 This issue was crucial to the outcome of the case. Classifying the
lab as a healthcare provider meant that medical malpractice statutes would
apply. 58 If the district court treated the claims as medical malpractice-as
opposed to ordinary negligence-the statute of limitations could bar the

Complaint for Petitioner, supra note 43, at 6. Note that we do not mean to imply that a
single study makes for a diagnosis. Rather the studies provided some evidence of
pathogenicity, arguably making the VUS determination inaccurate, as evidenced by the lab's
later reclassification in Williams' subsequent report. See infra note 52 and accompanying
text. The issue here is not whether a variant was actually widely accepted by the medical
literature and community as pathogenic, but rather that the lab had-using their specific
internal guidelines-reclassified it as such. There are important threshold issues about when
a variant is declared pathogenic, which are beyond the scope of this Article.
46 Complaint for Petitioner, supra note 43, at 12-13.
47
Id. at 15.
45

48
49

Id.

50

Id. at 16.
Williams v. Quest Diagnostics, Inc., 353 F. Supp. 3d 432, 437 (D.S.C. 2018).

51

Id.

52 Id.

See Complaint for Petitioner, supra note 43, at 16 (stating that the plaintiff, Williams,
submitted an affidavit prepared in anticipation of litigation, signed by Dr. Max Wiznitzer, a
pediatric neurologist board-certified by the American Board of Pediatrics and by the
American Board of Psychiatry and Neurology).
54 Wihams, 353 F. Supp. 3d at 437.
55
Id. at 436.
56
Id. at 438.
53

57

Id.

58

Id. at 440.

Published by LAW eCommons, 2020

7

Annals of Health Law, Vol. 29 [2020], Iss. 1, Art. 5

Annals of Health Law and Life Sciences
case.5

9

Vol. 29

Given that Christian's treating physician requested the genetic testing

for the purposes of diagnosis and treatment, the South Carolina Supreme
Court determined that the clinical genetics laboratory is a healthcare provider
for medical malpractice purposes four to one.60
How to classify clinical laboratories for purposes of medical malpractice
is a matter of state law. Sometimes, the text of the medical malpractice statute
explicitly defines healthcare provider. 6' Other times, as in Williams, courts
make these determinations. Ultimately, whether a certain provider falls
within the definition of healthcare provider differs from state to state. We
therefore conducted a fifty-state survey to assess the current doctrinal
landscape.
Survey Results
Whether clinical laboratories are healthcare providers for medical
malpractice purposes will often turn on the applicable statutes and how courts
construe them. We surveyed the statutes and relevant judicial opinions in
each state to determine whether a clinical laboratory providing genetic testing
services would likely be categorized as a healthcare provider.
By way of quick overview, we found that twenty-five states have no clear
statutory provisions or caselaw on this issue. Thus, half of states have no
definitive answer to this important legal question. Six states expressly
include laboratories or laboratory personnel in their statutory definition of
healthcare provider. In the face of statutory ambiguity, courts in fifteen states
have held that the definition of healthcare provider includes clinical
laboratories. By contrast, courts in four states have concluded that labs are
not healthcare providers. We detail our findings below.
LABS AS

PERCENTAGE

HEALTHCARE

(#)

STATES

PROVIDERS

59
6

1

Yes, by statute

12% (6)

Colorado, Hawaii, Louisiana, Montana,
Nevada, North Carolina

Yes, according to
caselaw

30% (15)

Alabama, Arkansas, California,
Connecticut, Florida, Georgia, Illinois,
Indiana, Maryland, Massachusetts,
Michigan, New York, Ohio, South

Id. at 443.
Williams v. Quest Diagnostics, Inc., 423 S.C. 547, 565 (2018).

61 See e.g., S.C. CODE ANN. § 15-79-110 (West 2019) (defining "healthcare provider" as "a

physician, surgeon, osteopath, nurse, oral surgeon, dentist, pharmacist, chiropractor,
optometrist, podiatrist, or any similar category of licensed healthcare provider, including a
healthcare practice, association, partnership, or other legal entity").
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Carolina, Texas

No, according to
caselaw
Maybe, not
enough
information

8% (4)
50% (25)

Maine, Rhode Island, South Dakota,
Virginia
Arizona, Alaska, Delaware, Idaho,
Kentucky, Kansas, Iowa, Mississippi,
Minnesota, Missouri, Nebraska, New
Mexico, New Jersey, New Hampshire,
North Dakota, Pennsylvania, Oregon,
Oklahoma, Tennessee, Vermont, Utah,
Wyoming, Wisconsin, West Virginia,
Washington

Unresolved Status
In twenty-five states (50%), it is unclear if clinical laboratories are health
care providers for medical malpractice purposes. This ambiguity exists for
two reasons. First, the medical malpractice statutes make no direct reference
to clinical laboratories. Next, no available caselaw interprets the statute to
apply-or to not apply-to labs.
Take Pennsylvania, for example. A search of the National Institutes of
Health's Genetic Testing Registry reveals three genetic testing labs located
and certified in Pennsylvania.62 In relevant part, Pennsylvania's Health Care
Services Malpractice Act reads:
Health care provider. A primary health care center . . . or a person,
including a corporation, university or other educational institution licensed
or approved by the Commonwealth to provide health care or professional
medical services as a physician, a certified nurse midwife, a podiatrist,
hospital, nursing home, birth center, and an officer, employee or agent of
63
any of them acting in the course and scope of employment.
Pennsylvania's statute does not reference clinical laboratories, nor does it
mention genetic testing services.64 Based on the statutory language, one
could argue that a clinical laboratory that is licensed by the Commonwealth,
certified under the federal Clinical Laboratory Improvement Amendments of
62

See Genetic Testing Registry, NAT'L CTR. BIOThCHNOLOGY INFO,
https://www.ncbi.nlm.nih.gov/gtr/ (last accessed Nov. 9, 2019) (displaying a database which
includes all clinical laboratories providing genetic testing services located and certified in
each state, which can be filtered by search restrictions, such as whether the lab is certified
under the Clinical Laboratory Improvement Amendments).
63 40 PA. STAT. ANN. § 1303.503 (West 2019).
64
Id.
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1999 (CLIA), and providing genetic testing services that aid medical
diagnoses falls within the definition. The results of our survey indicated,
however, that no court has decided that issue.
Explicitly Included by Statute
Six states (12%)include clinical laboratories or laboratory personnel in
67
66
65
their statutory definitions of healthcare provider: Colorado, Hawaii,
Louisiana,68 Montana,6 9 Nevada,70 and North Carolina. 7' Colorado's
definition of healthcare institution includes "a laboratory certified under
[CLIA] to perform high complexity testing., 7 2 A 2010 amendment to the
Louisiana Medical Malpractice Act added licensed clinical laboratories to the
definition of health care providers, explicitly noting that a healthcare
provider "means a ...licensed clinical laboratory scientist., 73 As an aside,
the legislature also planned to increase medical malpractice damages caps.74
Adding clinical lab personnel to the definition ensured that they would also
be subject to the new caps.75
Likewise, Hawaii's law includes "clinical laboratory technologist[s] or
technician[s] .76 Montana's medical malpractice law governs actions brought
for injury or death "against a . ..clinical laboratory bioanalyst, clinical
' 77
laboratory technologist, . . . or licensed medical professional corporation.
The Nevada statute's healthcare provider definition expressly includes a
"medical laboratory director or technician." 7s Lastly, North Carolina medical
79
malpractice law covers any person conducting a "laboratory analysis.

65 COLO. REV. STAT. ANN.

§ 13-64-202 (West 2019); HAW. REV. STAT.

§ 657-7.3

(West

2019); LA. STAT. ANN. § 40:1231.1 (West 2019); LA. STAT. ANN. § 40:1231.1 (West 2019);
MONT. CODE ANN. § 27-2-205 (West 2019); NEV. REv. STAT. ANN. § 41A.017 (West 2019);
N.C.GEN. STAT. ANN. § 90-21.11 (West 2019).
66 COLO. REV. STAT. ANN. § 13-64-202 (West 2019).
67HAW. REV. STAT. § 657-7.3 (West 2019).
68
LA.STAT. ANN. § 40:1231.1 (West 2019).
69 MONT. CODE ANN. § 27-2-205 (West 2019).
70 NEV. REv. STAT. ANN. § 41A.017 (West 2019).
71 N.C. GEN. STAT. ANN. § 90-21.11 (West 2019).
72 COLO. REv. STAT. ANN. §

13-64-202 (West 2019).

732010 La. Sess. Law. Serv. 1 Act 568 (H.B. 264) (West).
74 Rose Valazquez, Raise $500, 000 Cap on Louisiana MedicalMalpracticeDamages?Not

So Fast,LegislatorsSay, NEW ORLEANS ADVOCATE (Apr. 14, 2017),

https://www.nola.com/news/politics/article-b5f69eff-7264-5011-be9e-90ffb67a99df.html.
75

See

FRANKLIN D. BEAHM ET AL., UPDATES AND HANDLING POTENTIAL

PROBLEMS/DIFFICULTIES IN PROFESSIONAL MEDICAL NEGLIGENCE CASES 8 (20 10).
76 HAW. REV. STAT.
657-7.3 (2019).

§

77 MONT. CODE ANN.

§ 27-2-205 (West 2019).
§ 41A.017 (West 2019).
§ 90-2 1.11 (West 2019).

78 NEV. REv. STAT. ANN.
79
N.C. GEN. STAT. ANN.
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a iauvi-tU

Hawaii

Louisiana

Montana

Nevada

North
Carolina

REV.
STAT.
ANN. §
13-64202
(West).

certified
under [CLIA]
to perform
high
complexity
testing"

HAW.

"clinical

REV.
STAT. §
657-7.3
(West).

laboratory
technologist
or technician"

LA.
STAT.
ANN. §
40:1231.
1.
MONT.

means a...
licensed
clinical
laboratory
scientist"
"clinical

CODE
ANN. §
27-2-205.

laboratory
bioanalyst,
clinical
laboratory
technologist"

NEV.
REV.
STAT.
ANN. §
41A.017
(West).
N.C.
GEN.
STAT.
ANN. §
90-21.11
(West).

"medical
laboratory
director or
technician"

"laboratory
analysis"

2 years

6 years

1 year

3 years

2 years if

5 years

filed before
July 1, 2019

agreement
shall be a
voluntary
agreement
between a
patient and a
healthcare
provider
Must be heard

umbrella cap,
$350,000 cap
on
noneconomic
damages

$375,000 cap

by a
screening
panel before
trial or submit
the case to
arbitration
Must be heard
by a
screening
panel before
trial
Must be heard

on pain and
suffering
damages
(applicable to
all tort actions)

by a
screening
panel before
trial

on
noneconomic
damages

$500,000
actual
damages plus
future medical
expenses
$250,000 cap

3 years if
filed on or
after July 1,
2019
1 year

3 years

Parties shall
attend
settlement
conference
before trial

$350,000 cap
on
noneconomic
damages

1 year

3 years

Parties may
agree to

$569,247 cap
on

submit the
dispute to
arbitration
before or after
the action has
been filed

noneconomic
damages

Included,According to Caselaw

In fifteen of the states (30%) where malpractice statutes do not explicitly
address laboratories, courts have decided that clinical labs are healthcare
providers. Of course, in all cases, whether a lab is a healthcare provider
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depends on the facts. For example, two cases involved plaintiffs being
misinformed of genetic risks. s° Clinical laboratories, however, offer many
kinds of services. Although the focus of this paper is on laboratories that
perform genetic testing, the caselaw addresses laboratories that performed a
diverse set of tests. Hence, if genetic testing was not at issue, one cannot say
definitively that courts would rule similarly in a case involving genetic
testing services. While we recognize that these cases may ultimately not be
controlling, they would likely be an authority that a court would use for
guidance in claims involving genetic testing.
Of the decisions finding labs to be healthcare providers under state
malpractice law, most relied on the labs' providing services closely linked to
a doctor's diagnosis.81 Williams is a prime example. In reaching its decision,
the South Carolina Supreme Court noted that a clinical laboratory performs
genetic tests at the request of a treating physician 2 for the purpose of
assisting the treating physician in making a diagnosis.83 Diagnostic testing,
the court noted, is a core function of hospitals, and hospitals are clearly
included in the definition of licensed healthcare providers.84 The South
Carolina statute provides that "any similar category of licensed healthcare
providers" is subject to liability under the law.85 Given the similarity to
hospitals, the court held that a genetic testing laboratory clearly fell within
that catchall category.86
Likewise, the Alabama Supreme Court decided the issue based on the
Alabama statute's definition of "other healthcare providers," which includes
"[a]ny professional corporation or any person employed by physicians,
dentists, or hospitals who are directly involved in the delivery of healthcare
services."87 The court emphasized that the physician asked the lab to analyze
the patient's sample, and that the test was directly linked to the physician's

80 Johnson v. Superior Court, 101 Cal. App. 4th 869, 879 (2002); Pascarelli v. Coming
Clinical Labs., Inc., No. 325312, 1997 WL 155381 (Conn. Super. Ct. Mar. 25, 1997).
81See, e.g., Andersonv. Ala. Reference Labs., 778 So. 2d 806 (Ala. 2000); Johnson, 101
Cal. App. at 879; Baskette v. Atlanta Ctr. for Reproductive Med., LLC, 285 Ga. App. 876,
648 S.E.2d 100 (2007); Woody. Schuen, 760 N.E.2d 651, 653 (Ind. Ct. App. 2001);
Loudermilk v.Prof'l Lab. Serv., 75AP-219, 1975 WL 181821, at *2 (Ohio Ct. App. Oct. 7,
1975), adhered to on denial of reconsideration, 75AP-219, 1975 WL 182033 (Ohio Ct. App.
Dec. 18, 1975); Palonis v. Jewel Food Stores, Inc., 383 F. Supp. 2d 1072 (N.D. Ill. 2005);

Annunziatav. Quest Diagnostics, Inc., 127 A.D.3d 630, 631, 8 N.Y.S.3d 168, 169 (N.Y.
App. Div. 2015); Williams v. Quest Diagnostics, Inc., 816 S.E.2d 564, 565 (S.C. 2018).
82 Williams, 816 S.E.2d at 565.

Id.
84 Id. But note that all of Athena's tests were "send-outs," a point the court fails to consider
83

at
all in the analysis.
85
Id.(quoting S.C. CODE ANN. § 38-79-410).
86

Id.

87 Anderson v. Ala. Reference Labs., 778 So. 2d 806, 809-10 (Ala. 2000) (quoting ALA.
CODE § 6-5-481(8) (1975)).
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diagnosis and treatment.8 8
Court decisions in other states relied on similar factors. Some considered
whether the actions of the laboratory had caused medical injury. 0 Others
looked to how closely the laboratory's services were related to human
health.90 To some courts, the physician's involvement in directing the lab's
services was important.9 ' The physicians decided which tests and services
were necessary. 92 Ultimately, the data reveal that-regardless of the variation
among the statutes themselves-the relationship between the laboratory's
services, medical decision-making, and the consequences of those choices
were key to establishing liability.
Alabama

Alabama Medical
Liability Act of
1987, Code 1975,
§§ 6-5-542(1),
6-5-481(8)

Anderson v.Ala.
Reference Labs., 778
So.2d 806 (Ala.
2000)

Action brought against
medical reference laboratory
for negligently, wantonly, or
recklessly performing
tuberculosis testing. Plaintiff
claimed the lab committed
"legal fraud" in reporting
false test results, thereby
causing severe emotional
distress, economic losses,
and loss of consortium.

Because the testing was
directly linked to the doctor's
diagnosis, the laboratory fell
within definition of "other
health care provider" of
Alabama Medical Liability
Act of 1987 (AMLA), such
that patient's medical
malpractice action was subject
to the AMLA.

Arkansas

ARK. CODE ANN.
§ 16-114-201
(West)

Green v.Nat'l
Health
Labs. Inc.,
316 Ark.
5,7,870 S.W.2d
707,708(1994)

Laboratory and physician are
sued under the state's
malpractice statute for
issuing an erroneous positive
test result for cancer.

The Supreme Court of
Arkansas allows claims to
proceed under malpractice
statute, considering the actions
at issue to fall under "medical
injury" as defined by the law.

California

CAL.CIV.PROC.
CODE ANN. § §
3333.2,
425.13
(West)

Johnson v.Superior
Court, 101 Cal. App.
4th 869, 879, 124
Cal. Rptr. 2d 650,
658 (2002)

Medical malpractice action
against sperm bank and
bank's physicians, arising
from hereditary kidney
disease the child inherited
from spern donor
(misinformed of genetic
risk).

Cryobank is a healthcare
provider as that termis used in
the statute because it is a
licensed clinical laboratory.
The court found that the lab's
services were "inextricably
identified with the health of
humans." The lab's services,
while not essential to human
health, were related to human
health, and as such, the lab
was a healthcare provider
under the statute. 101 Cal.
App. 4th 869, 880, 124 Cal.
Rptr. 2d 650, 659 (2002).

88 Id. at 810.
89 See, e.g., Greenv. Nat'l Health Labs., Inc., 870 S.W.2d 707, 709 (Ark. 1994) (stating

laboratory caused "medical injury"); Pascarelli v. Coming Clinical Labs., Inc., No. 325312,
1997 WL 155381, at *2 (Conn. Super. Ct. Mar. 25, 1997) (noting that an HIV test was
incorrectly reported as positive by a clinical laboratory).
90 See, e.g., Johnsonv. Superior Court, 124 Cal. Rptr. 2d 650, 658 (Cal. Ct. App. 2002)
(stating the lab's services were "inextricably identified with the health of humans").
91 Baskette, v.Atlanta Ctr. for Reprod. Med., LLC, 648 S.E.2d 100, 104 (Ga. Ct. App.
2007); Annunziata, v. Quest Diagnostics, Inc., 8 N.Y.S.3d 168, 168 (N.Y. App. Div. 2015).
92 See, e.g., Baskette, 648 S.E.2d at 104 (noting that tests are performed under supervision of
physicians, who exercise of medical knowledge and judgment); Annunziata, 8 N.Y.S.3d at
168 (stating that the lab's services were provided at the direction of a physician).
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Connecticut

Vol. 29

CONN. GEN.
STAT ANN. § 52-

Pascarelli v. Coming
Clinical Labs., Inc.,

Proceeding instituted against
Coming Clinical

The court found that, under the
broad language of the statute,

184b (West)

325312, 1997 WL

Laboratories, Inc., a blood

the blood testing facility could

155381, at *2 (Conn.
Super. Ct. Mar. 25,
1997)

testing facility. Plaintiff
asserted that Coming
performed an analysis of his
blood and concluded that he
was HIV positive.
Subsequent tests revealed
the test results were in error.
A key inquiry was whether a
blood testing facility fell
under the statute's definition
of a healthcare provider.

reasonably be characterized as
a facility licensed by this state
to provide professional health
services. There were enough
similarities between the blood
testing facility and a pharmacy
and pharmacists, previously
held to be healthcare providers
under the law, for the court to
conclude the lab also fell
within the statutory definition.

Florida

West's F. S.A. §§
766

Nehme v. Smithkline
Beecham Clinical
Labs., Inc., 822 So.
2d 519, 520-21 (Fla.
Dist. Ct. App. 2002),
approved, 863 So. 2d
201 (Fla. 2003)

Action against clinical
laboratory for medical
malpractice and wrongful
death, arising from
misdiagnosis of pap smear,
which indicated presence of
malignancy.

Court assumes the lab is a
medical provider. Actions for
medical malpractice and
wrongful death brought by
personal representative of
patient's estate against clinical
laboratory were governed by
four-year statute of repose for
malpractice actions.

Georgia

GA. CODE ANN.
§ 9-3-70 (West)

Baskette v. Atlanta
Ctr. for Reproductive
Med., LLC, 285
Ga.App. 876, 648
S.E.2d 100 (2007)

Plaintiffs brought claim
against lab for the loss of
husband's sperm. The state
law's terms stated that an
"action for medical
malpractice" included any
claim for damages resulting
from an injury to any person
arising out of a medical
service rendered by any
person acting under the
supervision and control of a
lawfully authorized person.

The lab's services involved the
exercise of professional
medical knowledge and
judgment. Claims against
medical center, technologist,
and lab director constituted
claims for medical
malpractice, rather than for
ordinary negligence.

Illinois

735 ILL.COMP.
STAT ANN. 5/2622

Palonis v. Jewel
Food Stores, Inc.,
383 F. Supp. 2d 1072
(I.D. Ill. 2005)

Employee, a truck driver
who was terminated after he
tested positive for cocaine,
brought suit for negligence
against laboratory that tested
his urine sample.

The center was a medical
facility, technologist and
director thawed and used
patient's husband's sperm to
fertilize patient's eggs, and
they performed those tasks
within the scope of their
employment and under the
supervision of physicians.
In collecting, handling, and
testing his urine samples for
drugs and in reporting results
to his employer; laboratory's
alleged negligence did not
arise from application of
"healing art," but rather
laboratory acted in context of
employer-mandated drug test
given for purposes of
detennining employee's
eligibility to continue working,
not for purpose of diagnosing
or treating him. Had the tests
been performed for that
reason, however, malpractice
would have been applicable.

Indiana

IND.CODE ANN.
§ 34-18-2-14
(West)

https://lawecommons.luc.edu/annals/vol29/iss1/5

Wood v. Schuen, 760
N.E.2d 651, 653
(Ind. Ct. App. 2001)

Patient filed medical
malpractice claim against
director of cytopathology at
medical laboratory that
allegedly misread patient's
tests and failed to diagnose
cervical cancer.

Because there was no direct
nexus between the director's
actions and the alleged
negligence upon which the
claim was based, there was no
liability in this case.
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The court noted, however, that
persons whose lab results were
misread by a lab are not
without remedy. But the court
emphasized the need for a
"direct nexus between the
director's actions and the
alleged negligence upon which
the claim of medical
malpractice is based." 760
N.E.2d651, 659 (Ind.
Ct.App.
2001) (emphasis added).

Maryland

MD.CODE ANN.,
CTS.& JUD.
PROC. § 3-2A-01
(West)

Young v.Medlatic
Labs., 125 Md.App.
299, 725 A.2d 572
(1999)

Patient sued laboratory that
had performed pathology
tests on her tissue samples,
alleging that laboratory was
negligent in commuicating
results to patient's physician.

Claim proceeds as a medical
malpractice claim and is not
barred by statute of limitations
but court doesn't analyze the
statute.

Massachusetts

MASS. GEN.
LAWS ANN. ch.
231, § 60B
(West)

Morgan v.Lab.
Corp. of Am.,65
Mass. App. Ct.816,
844 N.E2d 689, 19
A.L.R.6th
923 (2006)

Negligence claims against
clinical laboratory that
analyzed patient's postsurgery blood tests, alleging
in part
that laboratory failed
to provide prompt notice to
surgeon that laboratory's
analysis of patient's blood
sample had revealed lifethreatening change in
anticoagulation level of
patient's blood.

In this case, an instruction on
medical malpractice caps was
in error, because the claims
brought were ordinary
negligence claims. The court
held that the evidence was
sufficient for the jury to find a
clinical laboratory's commonlaw negligence in failing to
promptly notify the doctor.
Medical malpractice liability
for the lab, however, may have
been applicable under
different facts.

Michigan

MICH. COMP.
LAWS ANN. §
600.2912b (West)

Herrmann v.Pinkus
Dematopathology
Labs., P.C.,
198380,
1998 WL 2016556,
at -1 (Mich. Ct.App.
Mar. 20,1998)

Plaintiffs alleged that
defendant lab failed to
indicate that the portion of a
lesion remaining after a
biopsy on decedent's
shoulder was potentially
dangerous and because of
that he failed to demand an
immediate, complete
excision of that remaining
portion.

Court analyzes the facts under
the standards for a medical
malpractice action.

New York

N.Y.C.P.L.R.
214-a
(McKinney)

Annunziata v.Quest
Diagnostics, Inc.,
127 A.D.3d630, 631,
8 N.Y.S.3d
168, 169
(N.Y.App. Div.
2015)

Complaint alleged that
Quest, a laboratory, was
negligent in misreading the
tissue sample.

Laboratory services performed
at the direction of a physician,
are an integral part
of the
process of providing medical
treatment. The court found
that a claim stemming from
the rendition of such services
is a medical malpractice claim.

Ohio

OHIO REV. CODE
ANN. § 2305.234
(West)

Loudermilk v.Prof I
Lab. Serv., 75AP219, 1975 WL
181821, at *2 (Ohio
Ct.App. Oct. 7,
1975), adhered to on
denial of
reconsideration,
75AP-219, 1975 WL
182033(Ohio
Ct.
App. Dec. 18,1975)

In an action brought against
a clinical laboratory, the
main issue for detennination
was whether an action
for medical malpractice
could lie against any person
performing testing services
for the plaintiff.

In order for
a medical malpractice action
to be appropriately brought,
there must have been a
professional medical service
rendered or performed.
Secondly, for such an action to
properly lie, there must be a
showing of the physicianpatient relationship. The court
detennined that the services
being performed by the lab
were professional medical
services and determined that a
physician-patient relationship
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existed.

South Carolina

Texas

S.C.CODEANN.
Williams v.Quest
§§ 15-79-110(4),Diagnostics, Inc.,
38-71-1920(7),
423 S.C.547, 816
38-79-410
S.E.2d
564(2018)

Suit for wrongful death
federally licensed
against
genetic testing laboratory
and related entities, based on
allegation that laboratory
staff failed to properly
detennine, at treating
physician's request, patient's
medical condition.

A genetic testing laboratory
that performs testing
at the
request of a patient's treating
physician forthe purpose of
assisting the treating physician
in detecting an existing disease
or disorder falls within the
statutory definition of
"licensed health care
providers." Testing was
performed at the request of a
treating physician for the
purpose of diagnosis and
treatment, which is a core
function of hospitals in
diagnosing and treating
patients.

Texas Medical
Liability
Insurance
Improvement Act
(MLIA), TEX.
CIV.PRAC.&
REM. CODE §
74.351(a)
(Vernon 2005)

Patient brought healthcare
liability claim against
laboratory and laboratory
technician, seeking damages
arising out of lab's failure to
recognize abnornal cells in
patient's pap smear.

Laboratories are not
presumptively excluded from
the definition of "health care
providers" under the statute.
But because the record did not
contain any evidence
establishing that LabCorp was
"duly licensed, certified, or
registered or chartered by the
State of Texas to provide
health care," or that LabCorp

Brown v.Villegas,
202 S.W.3d803, 804
(Tex. App.-San
Antonio 2006, no
pet.)

was an independent contractor
of the treating physician, the
trial
court's order applying
malpractice principles was
reversed.

Excluded, According to Caselaw
Finally, courts in four different jurisdictions (8%)-South Dakota, Rhode
Island, Virginia, and Maine-have explicitly decided not to define clinical
laboratories as healthcare providers. 93 In three of the four states, the states'
highest court rendered the decision.94 Although these cases held that clinical
laboratories were not subject to medical malpractice claims, some left open
the possibility that different facts might lead to different outcomes. 9
The Virginia Supreme Court held that a clinical laboratory was not a
healthcare provider in 1988.96 The medical malpractice statute did not
explicitly mention labs, and the court declined to construe it to include
93See Dupuis v. Cancer Screening Servs., No. CIV. 96-169-P-C., 1997 WL 97110, at *4 (D.

Me. Feb. 13, 1997); Ho-Rathv. R.I. Hosp., 89 A.3d 806, 812 (R.I. 2014); Sander v. Geib,
506 N.W.2d 107, 124 (S.D. 1993); Richmanv. Nat'l Health Labs., 367 S.E.2d 353, 357 (Va.
1988).
9 Ho-Rath, 89 A.3d at 806; Richman, 367 S.E.2d at 353; Sander, 506 N.W.2d at 107.
95 See, e.g., Dupuis, 1997 WL 97110, at *4 (stating clinical laboratory did not have direct

patient contact); Ho-Rath, 89 A.3d 806 at 812 (noting that laboratories having no direct
patient contact and provide only testing services which are not included in statute).
96Richman, 367 S.E.2d at 357.

https://lawecommons.luc.edu/annals/vol29/iss1/5

16

Foulkes et al.: Can Clinical Genetics Laboratories be Sued for Medical Malpractic

2020

Annals of Health Law and Life Sciences

them. 9 7 Further, the court held that the lab-licensed by the federal
government and not the Commonwealth-was both excluded from the
statutory list of healthcare providers and not acting as the doctor's agent. 9 A
1992 lower court decision relied on that case, noting that "[r]ules of liberal
construction cannot properly be applied to rewrite a statute in order to alter
what it actually says." 99
South Dakota Supreme Court used a slightly different line of reasoning in
1993, when deciding whether the lab was a "practitioner of the healing arts,"
within the meaning of the state's medical malpractice statute. 100 Because
previous caselaw-as well as the plain text of the statute-required a
"practitioner" to be a natural person, the court held that the clinical lab did
not fall within the statute's ambit101
A federal district court, applying Maine state law, came to a similar
conclusion in 1997.12 Despite the fact that courts had construed the state's
medical malpractice statute liberally, the court found that the statute did not
cover the clinical laboratory. 0 3 The defendant laboratory had no direct
contact with patients. The court concluded that evaluating tissue samples
'
and reporting results did not constitute "medical services. "105
The
court,
06
apply.
not
did
statute
malpractice
medical
the
that
found
therefore,
In 2014, the Rhode Island Supreme Court arrived at the same
conclusion. 0 7 The court held that, because the lab had no direct patient
contact and provided only testing services, the lab's actions did not fall under
the medical malpractice statute.108

Maine

97

NW.REV. STAT.tit. 24,

Dupuis v. Cancer

Patient brought a claim

The defendant laboratory had no

§ 2502

Screening Servs.,

againlst a clinical

direct contact with patients; its

Id.

9' Id. (noting that the text of the Commonwealth's statute indicated that covered institutions
had to be licensed by the Commonwealth and that the lab was inspected by the
Commonwealth and licensed by the federal government).
99 Nevitt v. Va. Heart Surgery Assocs., P.C., No. 109236, 1992 WL 884702, at *1 (Va. Cir.
May 28, 1992) (citing Richman, 367 S.E.2d at 357).
100 Sander, 506 N.W.2d at 124.
101 Id.
102 Dupuis v. Cancer Screening Sews., No. CIV. 96-169-P-C., 1997 WL 97110, at *4 (D.
Me. Feb. 13, 1997).
103 Id. ("Rules of liberal construction cannot properly be applied to rewrite a statute in order
to alter what it actually says.").
104 Ird.
105

Id.

106 Id.
107

Ho-Rathv. R.I. Hosp., 89 A.3d 806, 812 (R.I. 2014).
at 810, 812.

108Id.
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1997 U.S. Dist.

laboratory for medical

evaluation of tissue samples and

LEXIS 2456 *12

malpractice, claiming the

reporting results were not "medical

(D.Me. Feb. 13,

laboratory had

services," and the court, therefore,

1997)

negligently performed

found that the medical malpractice

cancer screening tests.

statute did not apply.
The lower court noted, however,
that the reach of the Act has been
interpreted liberally with regard to
claims brought against healthcare
providers.

Rhode

5 R.I. GEN. LAWS

Ho-Rathv. R.I

Parents brought action

Laboratories, having no direct

Island

ANN. §5-37-1 ( Vest)

Hosp., 89 A.3d

against numerous

patient contact and providing only

806 (R.I. 2014)

defendants alleging

testing services, did not fall under

negligence for injuries

the medical malpractice statute.

sustained by their minor
daughter, who was born

The court was of the opinion that,

with alpha thalassemia, a

in the absence of clear statutory

genetic blood disorder

language to the contrary, the
legislature did not intend for
negligence actions against
laboratories to fall under the ambit
of medical malpractice.

South
Dakota

S.D. CODIFIEDLAWS §

Sander v. Geib,

Patient brought medical

The court concluded that the

21-3 -11

Elston, Frost

malpractice action

language of the statute

Prof l Ass'n, 506

against clinical

and previous caselaw plainly

N.W.2d 107, 124

laboratory for alleged

required a "practitioner" to be a

(S.D. 1993)

negligence in reading of

natural person. The court held the

her pap smear slides. At

tern "other practitioner of the

issue was whether

healing arts" not to include entities

Clinical Lab is a
"practitioner of the

such as Clinical Lab, a medical
corporation.

healing arts" within the
meaming of the states

On occasion the court had found

medical malpractice

individuals to be "practitioner[s] of

statute.

the healing arts" even though they
were not licensed under the
Medical Practice Act. Unlike a
corporation. however,
those individuals were capable of
becoming licensed under the
Medical Practice Act.

Virginia

Virginia Medical

Nevitt v. Va.

The court considered the

"There is nothing about the nature

Malpractice Act, VA.

Heart Surgery

holding of a previous

of hospitals and nursing homes

CODE ANN. § 8.01-

Assocs., P.C., 38

case, Richman v.

which suggests that clinical

581.1 (West)

Va. Cir. 505

NationalHealth

laboratories, though not mentioned,

(1992)

Laboratories,235 Va.

should nevertheless be included in

353 (1988), finding that

the statute. Rules of liberal

an unlicensed lab did not

construction cannot properly be

fall within the ambit of

applied to rewrite a statute in order

the statute.

to alter what it actually says." 38
Va. Cir. 505,505 (1992).
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CONCLUSION

Genetic testing, given its rapid growth, will likely generate a good deal of
future litigation. Whether clinical genetics labs are healthcare providers is a
significant threshold inquiry. States have answered this important question
differently, and the answer a state provides may vary depending on the facts
of the particular case. The cases from our study are the starting point for any
practitioner's argument for-or against-treating a clinical genetics
laboratory as a healthcare provider under state medical malpractice law.
How states decide this issue will impact the outcomes of lawsuits against
clinical laboratories. If the labs are healthcare providers, they will be subject
to a given state's medical malpractice law, including statutes of limitations,
statutes of repose, damages caps, and procedural idiosyncrasies. Moreover,
in lieu of establishing ordinary negligence, plaintiffs will have to assert that
the laboratories breached the applicable standard of care. Perhaps our most
significant finding was that half of states have yet to tackle this issue directly.
Our other key finding was that, where labs have been subjected to
malpractice law, the relationship between the laboratory's services and
ordering physician was key to establishing liability. Because of the growing
importance of this question, we encourage state legislatures to weigh in to
provide clarity, in one way or another. In the meantime, healthcare attorneys
must keep careful watch as the law on this issue continues to develop.
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